Sofinnova Revenue and Competitors
Estimated Revenue & Valuation
- Sofinnova's estimated annual revenue is currently $11.8M per year.
- Sofinnova's estimated revenue per employee is $207,884
Employee Data
- Sofinnova has 57 Employees.
- Sofinnova grew their employee count by 2% last year.
Sofinnova's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Compliance Officer & Chief Operating Officer, Public Equity | Reveal Email/Phone |
2 | CFO & Partner | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | Chief Legal Officer | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | Director IR and Marketing, Private Equity | Reveal Email/Phone |
8 | Menlo Park Office Manager& Executive Assistant | Reveal Email/Phone |
9 | San Diego Office Manager & Executive Assistant | Reveal Email/Phone |
10 | Executive Assistant & Office Manager | Reveal Email/Phone |
Sofinnova Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.1M | 26 | 0% | N/A | N/A |
#2 | $4.6M | 29 | -3% | N/A | N/A |
#3 | $2M | 15 | -21% | N/A | N/A |
#4 | $21.3M | 94 | 34% | N/A | N/A |
#5 | $29.3M | 129 | 29% | N/A | N/A |
#6 | $22.7M | 100 | 56% | N/A | N/A |
#7 | $20.9M | 92 | -11% | N/A | N/A |
#8 | $4.1M | 26 | -4% | N/A | N/A |
#9 | $13.1M | 64 | 19% | N/A | N/A |
#10 | $7.6M | 49 | N/A | N/A | N/A |
What Is Sofinnova?
Sofinnova has been building Life Science and IT companies for over 30 years. We are constructive investors, assisting our portfolio companies with much more than money. Our mission is to create value by providing talented entrepreneurs with the resources, experience and network necessary to turn their bright ideas into great businesses.
keywords:N/A
N/A
Total Funding
57
Number of Employees
$11.8M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sofinnova News
Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases. Tue, April 19, 2022, 11:30 PM ·3 min read.
-based Sofinnova, the firm said. He most recently was chief medical officer of biotech startup Catamaran Bio Inc. and before that held the same...
Since 1976, Sofinnova has been active in life science investing. We are a biopharmaceutical investment firm with approximately $3.0B in assets...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.7M | 59 | -17% | $27.4M |
#2 | $14.3M | 59 | -5% | N/A |
#3 | $13.9M | 61 | 7% | N/A |
#4 | $7.5M | 61 | 11% | N/A |
#5 | $17.2M | 62 | 48% | N/A |